IDEXX Laboratories Inc. | Income Statement
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,377
1,486
1,602
1,775
1,969
2,213
Cost of Goods Sold (COGS) incl. D&A
623
674
733
804
872
971
Gross Income
755
812
869
972
1,097
1,243
SG&A Expense
485
555
582
625
684
748
EBIT
267
258
287
347
413
495
Unusual Expense
1
-
8
-
-
3
Non Operating Income/Expense
-
2
1
20
3
1
Interest Expense
4
14
28
32
37
35
Pretax Income
263
247
273
322
381
458
Income Tax
75
65
81
100
118
81
Consolidated Net Income
188
182
192
222
263
377
Net Income
188
182
192
222
263
377
Net Income After Extraordinaries
188
182
192
222
263
377
Net Income Available to Common
188
182
192
222
263
377
EPS (Basic)
1.74
1.79
2.05
2.44
2.94
4.26
Basic Shares Outstanding
106
100
93
90
88
87
EPS (Diluted)
1.74
1.79
2.05
2.44
2.94
4.26
Diluted Shares Outstanding
108
102
94
91
90
88
EBITDA
322
317
356
425
496
578
Other Operating Expense
2
-
-
-
-
-
Non-Operating Interest Income
2
2
2
4
5
1
Minority Interest Expense
-
-
-
-
-
-
About IDEXX Laboratories
View Profile
